Find Academic Supervisors

Richard S SmithView profile

Assistant Professor

• Neuroscience
• Developmental Neurobiology
• Ion Channel Research
• +5 more

Richard S Smith is an Assistant Professor in the Department of Pharmacology at Northwestern University's Feinberg School of Medicine, with secondary appointments in Pediatrics. His research integrates neurobiology, genetics, and translational medicine to investigate prenatal brain development and ion channel diseases. Education: PhD: Cotutelle Sorbonne University & University of Maryland (2015) Postdoctoral Fellow: Harvard Medical School / Boston Children's Hospital / Howard Hughes Medical Institute (2021) Faculty Instructor: Harvard Medical School-Dept of Pediatrics (2022) Dr. Smith's research focuses on prenatal channelopathies —developmental ion channel diseases originating during gestation. His lab investigates bioelectricity in brain development using innovative models including gyrencephalic ferrets (to study cortical folding unattainable in lissencephalic mice) and human iPSC-derived neuronal systems. Key projects examine ion channel diseases affecting brain development, bioelectricity in human cortical evolution, and high-throughput screening platforms for neuronal disease modeling. His work demonstrates how ion channels like ATP1A3, SCN3A, and GRIN variants regulate cortical formation and contribute to malformations. Analysis of his publication record reveals strong emphasis on translational neurogenetics , with recent work connecting rare genetic variants to brain malformations (JAMA Neurology 2023) and developing gene therapy approaches for potassium channel disorders (BioRxiv 2024). His research bridges molecular mechanisms with clinical neurology, particularly in pediatric channelopathies and neurodevelopmental disorders. Research Leadership: Director of Smith Lab (www.rsmithlab.com) Member of Center for Autism and Neurodevelopment Member of Center for Genetic Medicine Member of Northwestern University Clinical and Translational Sciences Institute (NUCATS) Member of Stephen M. Stahl Center for Psychiatric Neuroscience Dr. Smith employs cutting-edge approaches including single-cell technologies, ferret models of gyrification, and iPSC-based drug screening. His lab trains scientists in both advanced research techniques and addressing systemic challenges in scientific communities. While no formal awards are listed in available materials, his work has been published in high-impact journals including Nature, Neuron, and JAMA Neurology.

Akdes Serin HarmanciView profile

Assistant Professor

• Neurosurgery
• Computational Biology
• Genomics
• +5 more

Akdes Serin Harmanci is an Assistant Professor of Neurosurgery at Baylor College of Medicine, with prior roles as an Associate Research Scientist and Postdoctoral Researcher at Yale University and as an Assistant Professor at the School of Biomedical Informatics, University of Texas Health Science Center. She holds a PhD in Computational Biology from the Max Planck Institute for Molecular Genetics and a BS in Computer Science and Engineering from Sabanci University. Primary Affiliation: Assistant Professor, Department of Neurosurgery, Baylor College of Medicine Secondary Affiliations: Associate Research Scientist, Neurosurgery, Yale University; Assistant Professor, School of Biomedical Informatics, University of Texas Her research focuses on neurosurgery and computational biology, particularly the genomic and transcriptomic analysis of brain tumors. She employs advanced techniques such as single-cell RNA sequencing, multiomic profiling, and molecular diagnostics to study meningioma and glioma progression, radiation resistance, and immune interactions. Her work bridges clinical neurosurgery with computational methods to identify novel therapeutic targets and prognostic markers. The 15 most recent publications highlight her contributions to understanding: AAV vector transduction mechanisms in brain tissue, NF2-hypoxia synergy in meningioma radioresistance, CD83's immunomodulatory role in glioma, and the impact of genetic variants on tumor-immune dynamics. These studies span neurogenetics, tumor microenvironment analysis, and translational applications of genomic data.

Scott Nicholas FurlanView profile

Assistant Professor

• Graft-versus-host disease
• Hematopoietic cell transplantation
• T-cell therapy
• +3 more

Dr. Scott Nicholas Furlan is an Assistant Professor in the Translational Science and Therapeutics Division at Fred Hutchinson Cancer Center, with a secondary appointment as Assistant Professor in the Department of Pediatrics at the University of Washington School of Medicine. He is a member of the Immunotherapy Integrated Research Center (IIRC) and Translational Data Science Integrated Research Center (TDS IRC) at Fred Hutch. His clinical expertise includes hematopoietic cell transplantation, pediatric oncology, and acute myelogenous leukemia. Education: Post-doctoral Fellowship in Transplant Immunology, Seattle Children’s Research Institute (2012-2015) Fellowship in Pediatric Hematology Oncology, UT Southwestern Medical Center (2009-2012) Residency in Pediatrics, UT Southwestern Medical Center (2006-2009) MD, Keck School of Medicine at USC (2002-2006) Bachelor of Arts, Macalester College (1994-1998) Research Focus: Dr. Furlan employs single-cell genomics to study immune reconstitution after hematopoietic cell transplantation and cellular immunotherapies for pediatric cancers. His lab investigates graft-versus-host disease mechanisms, T-cell dysfunction, leukemia biology, and tumor microenvironments, with emphasis on translational applications for improving clinical outcomes. Publication Trends: Recent work (2023-2025) focuses on immunogenomics of transplantation, cellular therapies, and tumor biology. Key themes include T-cell exhaustion, microbiota-immune interactions, epigenetic profiling, and novel immunotherapy targets. Studies frequently integrate computational biology with translational models. Clinical & Lab Leadership: Dr. Furlan leads the Furlan Lab at Fred Hutch, which develops computational tools for single-cell analysis and conducts research in pediatric malignancies. He oversees clinical trials investigating tumor heterogeneity in leukemia and Ewing sarcoma.

Russell FinleyView profile

Professor

• Regulatory networks
• Cell cycle regulation
• Drosophila development
• +3 more

Russell Finley is a Professor at Wayne State University, with joint appointments in the Departments of Molecular Medicine and Genetics and Biochemistry, Microbiology, and Immunology. He serves as Division Director for Education and Graduate Officer in CMMG and is a member of the Karmanos Cancer Institute. His research focuses on regulatory networks controlling cell proliferation, using high-throughput technologies like yeast two-hybrid systems and RNAi screens. PhD in Molecular Biology from SUNY Upstate Medical University (1990) Postdoctoral training at Harvard Medical School and Massachusetts General Hospital (1990-1995) Research keywords include protein interaction networks, Drosophila development, cancer biology, and systems biology. His 2024-2010 publications highlight work on cell cycle regulators, pathogen interactions, and bioinformatics methodologies. He teaches advanced courses in cancer biology, molecular genetics, and systems biology.

Francesca LucaView profile

Assistant Professor

• Evolutionary Genetics
• Functional Genomics
• Human Evolution
• +5 more

Francesca Luca is an Assistant Professor at Wayne State University, jointly appointed in the Center for Molecular Medicine and Genetics and the Department of Obstetrics and Gynecology. Her research integrates evolutionary and functional genomics to explore genetic and molecular mechanisms underlying inter-individual and inter-population differences in complex traits. University : Wayne State University Academic Rank : Assistant Professor Email : fluca@wayne.edu Research Interests : Dr. Luca investigates how phenotypic differences evolved as humans adapted to changing environments, focusing on gene-environment interactions, nuclear receptor pathways (e.g., estrogen receptors), and health disparities. Her work employs functional genomics techniques like ChIP-seq and RNA-seq on diverse human populations. Publications : Recent studies include analyses of gene-environment interactions in SARS-CoV-2 responses (2023), single-cell placental transcription in preterm birth (2019), and evolutionary adaptations to dietary shifts (2010). She also explores host-microbiome interactions (2018) and genetic variations in NAT2 and SGK1 genes. Collaborative Work : Dr. Luca's lab collaborates on projects spanning pharmacogenomics, maternal-fetal medicine, and systems-level genetic characterization of health disparities. Her methodologies bridge evolutionary theory with clinical applications in obstetrics and gynecology.

Aivi T. NguyenView profile

Assistant Clinical Professor

• Neurodegeneration
• Alzheimer's Disease
• Microglia
• +3 more

Aivi T. Nguyen, M.D., serves as a Clinical Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. As a board-certified neuropathologist and translational researcher, she spearheads investigations into neuroinflammation mechanisms in neurodegenerative diseases through the Alzheimer's Disease Research Center (ADRC) and Mayo Clinic Study of Aging (MCSA), integrating neuropathology with neuroimaging and biomarker analysis. Her educational trajectory includes: Post Doctoral Fellowship, Translational Neuropathology Research Laboratory (University of Pennsylvania, 2020) Neuropathology Fellowship (Hospital of the University of Pennsylvania, 2018) Anatomic Pathology Residency (Hospital of the University of Pennsylvania, 2016) M.D. (Jefferson Medical College, 2014) Research Fellowship (NIH Medical Research Scholars Program, 2013) B.S. in Cell and Molecular Biology, Genetics (University of Delaware, 2009) Dr. Nguyen's research centers on microglial heterogeneity in Alzheimer's disease, employing single-nuclei RNA sequencing and immunohistochemical validation to characterize distinct microglial subpopulations. She investigates how genetic risk variants (APOE E4, TREM2 R47H) modulate microglial responses to proteinopathies and explores microglia's role in cognitive resilience despite pathological burden. Her work bridges molecular mechanisms with clinical manifestations through multidisciplinary approaches. Analysis of her 2020-2025 publications reveals consistent focus on microglial biology across neurodegenerative conditions, with increasing emphasis on genetic determinants and translational applications. Recent work expands into TDP-43 proteinopathies and cerebral amyloid angiopathy while maintaining core investigation of microglial dynamics in Alzheimer's disease. Her accolades include: Two Diagnostic Slide Session Awards for Best Neurodegenerative Case (American Association of Neuropathology, 2021 & 2018) Neurodegenerative Disease Scholars Program Award and Robert Terry Award Honorable Mention (2020) Penn Cares Grant for 'Woodland Writers' Project (2015) Harold L. Stewart Prize in Pathology (2014) Dr. Nguyen actively shapes neuropathology standards through committee roles including the American Board of Pathology Test Development Advisory Committee and American Association of Neuropathologists Education Committee. Her research is supported by institutional resources within Mayo Clinic's ADRC infrastructure and collaborative multi-institutional grants. She operates within Mayo Clinic's integrated research ecosystem, contributing neuropathological expertise to the ADRC and MCSA teams while participating in national consortia studying neurodegenerative mechanisms. Her laboratory work focuses on human tissue analysis with emphasis on microglial transcriptomics and spatial pathology mapping.

Peter W. ReddienView profile

Professor

• Regeneration
• Stem Cell Biology
• Developmental Biology
• +3 more

Peter W. Reddien is Professor of Biology at MIT, Member of the Whitehead Institute for Biomedical Research, and Howard Hughes Medical Institute (HHMI) Investigator. He serves as Associate Head of MIT's Department of Biology and leads regenerative biology research using planarian flatworms as a model system. Education: Undergraduate: Molecular Biology, University of Texas at Austin PhD: Biology, MIT (Advisor: Robert Horvitz) Postdoctoral: Stowers Institute (with Alejandro Sanchez Alvarado) Reddien's research focuses on the cellular and molecular mechanisms of regeneration. His lab discovered that planarians utilize pluripotent adult stem cells called neoblasts for tissue renewal and regeneration. They identified muscle tissue as the primary source of positional information during regeneration, mediated by position control genes including Wnt signaling components. This work revealed how coordinate systems guide stem cell behavior to rebuild correct anatomical structures. His publication trends demonstrate interdisciplinary approaches combining genomics, molecular biology, and imaging to map cell types and signaling pathways in regeneration. Recent work emphasizes single-cell transcriptomics and the role of tissue architecture in instructing regenerative outcomes across developmental biology and regenerative medicine fields. Awards: Helen Hay Whitney Foundation Fellow (2003) Rita Allen Scholar Award (2006) Searle Scholar Award (2006) Smith Family Award for Excellence in Biomedical Research (2006) Keck Distinguished Young Scholar (2008) HHMI Early Career Scientist (2010) Mossman Developmental Biology Award (2012) HHMI Investigator (2013) As an HHMI Investigator, Reddien directs substantial research funding supporting his lab's work on stem cell regulation and positional information. He mentors graduate students and postdoctoral fellows at MIT, with research implications for regenerative medicine and aging. Current projects explore Delta-Notch signaling in nervous system regeneration and molecular mechanisms of tissue patterning. The Reddien Lab operates at the Whitehead Institute in Cambridge, employing genomic tools and live imaging to study planarian regeneration. The team collaborates globally to investigate conserved regenerative mechanisms, with recent work featured in 2024-2025 news coverage on neoblast function and neural regeneration.

Mekayla A StorerView profile

Researcher

• Developmental Biology
• Stem Cell Biology
• Regenerative Medicine
• +4 more

Dr. Mekayla A Storer is a Group Leader at the Wellcome-MRC Cambridge Stem Cell Institute and an affiliate of the University of Cambridge's Physiology, Development and Neuroscience department. Her research focuses on the cellular and molecular mechanisms of blastema formation during mammalian digit tip regeneration, combining single-cell transcriptomics , genetic lineage tracing , and in vitro blastema cultures . Education : PhD from Centre for Genomic Regulation (Barcelona, Spain), supervised by Dr. Bill Keyes Postdoctoral Training : Drs. Freda Miller and David Kaplan at Hospital for Sick Children (Toronto, Canada) Her work explores how stem cells and senescence contribute to regeneration, with implications for therapies targeting broader tissue repair. Key publications include studies on blastema dynamics (2020), digit regeneration (2022), and a human embryonic limb cell atlas (2023). Laboratory Members : PhD Student: Jia Hua Wang Research Associates: Camille Dumas, Kentaro Hirose, Joseph Wong Biomedical Research Technician: Evelina Sliauteryte Postgraduate Student: Lauren Connolly

• Epidemiology
• Breast Cancer Risk Prediction
• Epigenetics
• +3 more

Carmen Petitjean is a PhD Research Student affiliated with the Department of Public Health and Primary Care at the University of Cambridge , and a member of the Cardiovascular Epidemiology Unit (CEU) . Her work focuses on epidemiological modeling and data analysis. Education BSc in Medical Biosciences, Imperial College London MPhil in Epidemiology, University of Cambridge Research Focus Validation of the BOADICEA breast cancer risk prediction model Epigenetic and single-cell transcriptomic data analysis Integration of genomic data for cardiovascular disease studies Affiliations Cardiovascular Epidemiology Unit (CEU) Primary Care Unit (PCU)

Sébastien TremblayView profile

Assistant Professor

• Neuroscience
• Psychiatry
• Neurotechnology
• +5 more

Sébastien Tremblay is an Assistant Professor in the Department of Psychiatry and Neuroscience at Université Laval’s Faculty of Medicine. He is also a researcher at CERVO, focusing on integrative neuroscience and experimental therapies. His work bridges psychology, engineering, gene therapy, and neurosurgery, with a strong emphasis on non-human primate models and neurotechnology development. MSc in Psychology, Université de Montréal PhD in Neuroscience, McGill University Postdoctoral Fellow, Montreal Neurological Institute Postdoctoral Fellow, Perelman School of Medicine, University of Pennsylvania Dr. Tremblay’s research centers on neurotechnology development for modulating brain activity , particularly in treating mental disorders. His team specializes in optogenetics , chemogenetics , wireless neurophysiology , and MRI-guided neurosurgery , prioritizing translational applications from primate models to human treatments. Key interests include understanding social behavior neural signatures and developing tools for clinicians. His publications highlight trends in primate neuroscience , neurotechnology , opioidergic systems , and traumatic brain injury . Recent work includes single-cell genomics, viral vector optimization, and social behavior neural decoding. 2023 Brain Star Award, Canadian Association for Neuroscience 2022 University of Pennsylvania’s Year of Neuromodulation Speaker 2020 Human Frontier Science Program Fellow 2019 Banting Fellow, CIHR 2018 MIT Hacking Medicine Health Innovation Prize ... + 20+ more awards Dr. Tremblay’s grants include Banting Fellowships , NSERC Scholarships , and institutional awards. His lab collaborates with institutions like the Allen Institute for Brain Science and MIT Hacking Medicine . The Translational Neurosurgery Laboratory at CERVO develops neurotechnologies for brain modulation. It focuses on non-human primate research , integrating psychology , engineering , and neurosurgery to create clinical tools for brain disease treatment.

Marte Lie HøivikView profile

Professor

• Clinical epidemiology
• Registry-based epidemiology
• Clinical effectiveness
• +5 more

Marte Lie Høivik is a Professor at the University of Oslo's Institute of Clinical Medicine, Department of Gastroenterology and Hepatology. She serves as Senior Consultant and Head of the IBD Unit at Oslo University Hospital, leading the IBD research group and directing the IBSEN III study. Her research focuses on clinical and registry-based epidemiology in inflammatory bowel disease (IBD), with emphasis on clinical effectiveness, quality studies, prognostic research, and biomarker identification. Her work leverages large population-based cohorts like IBSEN to investigate disease course, treatment outcomes, and quality-of-life impacts. Recent publications reveal strong trends in risk prediction modeling, microbiome analysis, therapeutic drug monitoring, and real-world treatment effectiveness. Her team frequently examines understudied aspects like fatigue in remission, dietary impacts, and sex/gender differences in IBD outcomes using longitudinal cohort designs. Høivik actively supervises research within the IBSEN III cohort and collaborates extensively across Nordic countries on IBD epidemiology. Her team has published over 30 papers since 2021 in high-impact journals including Nature , Gastroenterology , and The Lancet Gastroenterology & Hepatology . She leads multiple research projects including the IBSEN III cohort study and NORDTREAT, with current funding supporting investigations into biomarkers, treatment strategies, and long-term disease outcomes in inflammatory bowel disease.

Felix SommerView profile

Researcher

• Microbiome
• Host-Microbiome Interactions
• Immunology
• +6 more

Felix Sommer is a Researcher and Group Leader of the Functional Host-Microbiome Research group at the Institute of Clinical Molecular Biology (IKMB) of Kiel University and University Medical Center Schleswig-Holstein (UKSH). He heads the Systems Immunology Microbiome Platform and leads the Junior Research Group Functional Host-Microbiome Research and Systems Immunology, which was established in 2020. His work focuses on understanding the intricate interactions between the host, microbiome, and environmental factors in health and disease. Felix Sommer received his PhD in cell biology in 2010 from Kiel University and completed postdoctoral training in the lab of Fredrik Bäckhed in Gothenburg, Sweden, from 2010 to 2015 before joining IKMB. His research centers on host-microbiome interactions, particularly how the microbiome influences host metabolism (such as glycolysis) and immune responses, with implications for inflammatory bowel disease, cancer, and metabolic disorders. His work employs gnotobiotic in vivo conditional knockout models, functional in vitro organoid systems, and high-throughput 'omics' technologies including next-generation sequencing and metabolomics. Analysis of his recent publications reveals a strong focus on the metabolic aspects of host-microbiome interactions, particularly how microbial metabolites influence host immune responses and disease states. His work spans multiple disease models including inflammatory bowel disease, cancer, metabolic disorders, and aging, with a consistent theme of identifying specific molecular pathways that could be targeted therapeutically. Recent work has increasingly focused on hexokinase regulation, gut barrier function, and the therapeutic potential of microbiome modulation. Felix Sommer leads a research team that includes doctoral researchers Xue Gu, Hongshu Huang, Lea Järke, Xiangyu Meng, and Saskia Weber-Stiehl. His group is supported by funding from the German Research Foundation (DFG) for the project 'Role of DUOX2 in shaping the intestinal microbiota and effects on inflammation, cancer and metabolic disease' (SO1141/10-1), the Research Group 'miTarget – The Microbiome as a Target in Inflammatory Bowel Diseases' (FOR5042), and the Excellence Cluster 'Precision Medicine in Chronic Inflammation' (EXS2167). The Functional Host-Microbiome Research group operates within the Institute of Clinical Molecular Biology at Kiel University, utilizing specialized facilities including gnotobiotic models and advanced 'omics' technologies. The group aims to develop novel strategies for treating metabolic and inflammatory disorders by targeting the intestinal microbiome through nutritional or probiotic interventions, with a particular focus on understanding the molecular mechanisms underlying host-microbiome crosstalk.

Katherine T. MillsView profile

Associate Professor

• Cardiovascular Disease Epidemiology
• Renal Disease Epidemiology
• Implementation Science
• +5 more

Katherine T. Mills is an Associate Professor in the Epidemiology Department at Tulane University's School of Public Health and Tropical Medicine. Her research focuses on cardiovascular and renal disease epidemiology, implementation science, and health disparities, with particular emphasis on blood pressure control interventions and chronic kidney disease. Dr. Mills received her PhD in Epidemiology from Tulane University, completed a postdoctoral fellowship in cardiovascular disease epidemiology at Johns Hopkins University, earned an MSPH in Epidemiology from the University of North Carolina at Chapel Hill, and completed her undergraduate studies in Chemistry at Colorado College. Her research program spans multiple domains of public health and clinical epidemiology. Dr. Mills has established herself as a leader in studies examining the relationship between cardiovascular disease, kidney function, and health disparities. She has conducted extensive research on implementation science approaches to improve blood pressure control, particularly in underserved populations. Her work also investigates health outcomes in chronic kidney disease patients, including progression to end-stage renal disease, cardiovascular events, and mortality. Through her research, Dr. Mills has contributed significantly to understanding how social determinants of health impact cardiovascular outcomes and how community-based interventions can reduce health disparities. She has been particularly active in engaging Black churches as venues for cardiovascular health interventions. Analysis of Dr. Mills' recent publications reveals a strong focus on cardiovascular epidemiology, kidney disease outcomes, and implementation science for hypertension control. Her work frequently employs advanced statistical methods and large cohort studies, particularly the Chronic Renal Insufficiency Cohort (CRIC) study. She has published extensively on topics including blood pressure management, kidney disease progression, cardiovascular risk factors, and health disparities in minority populations. Her research often examines the intersection of social determinants of health with clinical outcomes. Dr. Mills has received numerous scientific awards including: 2020: Outstanding Achievement in Receiving Your First R01 Award 2018: Young Investigator Travel Award, NIH, NIGMS Seventh Biennial National IdeA Symposium of Biomedical Research Excellence (NISBRE) 2017: Sandra A. Daugherty Award for Excellence in Cardiovascular Disease for Hypertension Epidemiology, American Heart Association Council on Epidemiology and Prevention 2016: Award for Excellence in Research and Presentation by a Postdoctoral Fellow, Health Sciences Research Days, Tulane University 2015-2016: NIH/NHLBI T32 Cardiovascular Disease Epidemiology Training Program, Johns Hopkins University 2014: Dorothy R. LeBlanc Memorial Scholarship Award, Tulane University 2010-2012: Dean's Research Council Scholarship, Tulane University Dr. Mills has secured significant NIH funding for her research on blood pressure control interventions and health disparities. She has mentored numerous students and collaborated extensively with interdisciplinary teams across Tulane and other institutions. Her work on church-based interventions for cardiovascular health has been particularly influential in addressing racial health disparities. She has developed and tested multicomponent implementation strategies that engage community health workers and faith-based organizations to improve blood pressure control in low-income communities. Dr. Mills is actively engaged with the Chronic Renal Insufficiency Cohort (CRIC) study and has led multiple analyses examining cardiovascular outcomes in patients with chronic kidney disease. She collaborates with interdisciplinary teams including nephrologists, cardiologists, biostatisticians, and community health workers to address complex questions in cardiovascular and kidney disease epidemiology. Her current research focuses on identifying which populations benefit most from intensive blood pressure interventions and how social determinants of health influence treatment effectiveness.

Amanda W. LundView profile

Associate Professor

• Lymphatic Vessels
• Cutaneous Immunity
• Melanoma
• +6 more

Amanda W. Lund is an Associate Professor at the NYU Grossman School of Medicine , holding dual appointments in the Ronald O. Perelman Department of Dermatology and Department of Pathology. She also serves as Director of the PhD Curriculum at the Vilcek Institute. Education : PhD from Rensselaer Polytechnic Institute Postdoctoral Training : Laboratory of Lymphatic and Cancer Bioengineering at Ecole Polytechnique Federale de Lausanne Dr. Lund's research focuses on the critical role of lymphatic vasculature in cutaneous and tumor immunity. Her work explores how lymphatic vessels regulate adaptive immune responses, influence tumor immune escape, and impact metastasis dynamics. Key methodologies include 3D imaging , single-cell transcriptomics , and cell-specific proteomics to study these interactions in vivo. Her recent publications highlight lymphatic vessel contributions to T-cell trafficking in melanoma, immune surveillance mechanisms, and strategies to enhance cancer immunotherapy by targeting lymphatic-immune interfaces. Research trends show a strong emphasis on translational approaches bridging lymphatic biology with clinical oncology challenges. Contact: Amanda.Lund@nyulangone.org | Lab: Lund Lab

Sally MortlockView profile

Academic

• Genetics
• Genomics
• Epigenetics
• +4 more

Dr. Sally Mortlock is an Affiliate Senior Research Fellow at the Institute for Molecular Bioscience and a Senior Research Fellow at the School of Public Health, University of Queensland. With a PhD from the University of Sydney, her work focuses on the genetic and molecular mechanisms underlying endometriosis and related reproductive disorders. Positions: Institute for Molecular Bioscience, School of Public Health Key Research Areas: Genetics, Genomics, Epigenetics of endometriosis Her research integrates GWAS, epigenetic profiling, and multi-omics approaches to uncover genetic risk factors, gene-environment interactions, and molecular pathways in endometriosis. Recent work examines: Genetic regulation of endocannabinoid system in reproductive conditions Endometrial DNA methylation and disease risk scores Comorbidities with gastrointestinal/psychiatric disorders Scientific contributions include: Developing molecular staging models for endometrial biopsies Identifying pleiotropic genetic factors in endometriosis-depression links Characterizing endometriosis lesion subtypes through gene expression Dr. Mortlock actively supervises PhD students and has secured grants from: National Endometriosis Clinical and Scientific Trials Network (NECST) National Institutes of Health (NIH) National Health and Medical Research Council (NHMRC)